Global Antimicrobial Resistance Diagnostics Market Size & Outlook

The antimicrobial resistance diagnostics industry worldwide is expected to reach a projected revenue of US$ 6,705.8 million by 2030. A compound annual growth rate of 6.2% is expected of the worldwide antimicrobial resistance diagnostics industry from 2022 to 2030.
Revenue, 2021 (US$M)
$3,893.1
Forecast, 2030 (US$M)
$6,705.8
CAGR, 2022 - 2030
6.2%
Report Coverage
Worldwide

Global antimicrobial resistance diagnostics market, 2018-2030 (US$M)

Related Markets

Global antimicrobial resistance diagnostics market highlights

  • The global antimicrobial resistance diagnostics market generated a revenue of USD 3,893.1 million in 2021 and is expected to reach USD 6,705.8 million by 2030.
  • The market is expected to grow at a CAGR (2022 - 2030) of 6.2% by 2030.
  • In terms of segment, pcr accounted for a revenue of USD 961.9 million in 2021.
  • Rapid & Point of Care is the most lucrative technology segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2021.
  • Country-wise, Sweden is expected to register the highest CAGR from 2022 to 2030.

Global data book summary

Market revenue in 2021USD 3,893.1 million
Market revenue in 2030USD 6,705.8 million
Growth rate6.2% (CAGR from 2021 to 2030)
Largest segmentPcr
Fastest growing segmentRapid & Point of Care
Historical data covered2018 - 2020
Base year for estimation2021
Forecast period covered2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationMicrobiology Culture, Immunoassay, PCR, NGS, Mass Spectrometry, Rapid & Point of Care, Other Technology

Other key industry trends

  • In terms of revenue, the North America accounted for 42.8% of the global antimicrobial resistance diagnostics market in 2021.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Sweden is the fastest growing regional market and is projected to reach USD 25.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Antimicrobial Resistance Diagnostics Market Scope

Antimicrobial resistance diagnostics market segmentation & scope
Microbiology Culture
Immunoassay
PCR
NGS
Mass Spectrometry
Rapid & Point of Care
Other Technology
Drug Resistant Streptococcus Pneumoniae (DRSP)
Drug Resistant Campylobacter (DRC)
Clostridium Difficile (CD)
Methicillin Resistant Staphylococcus Aureus (MRSA)
Drug Resistant Neisseria Gonorrhoeae (DRNG)
Drug Resistant Salmonella (DRNTS)
Other Pathogen
Hospitals
Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Other End-user

Antimicrobial Resistance Diagnostics Market Companies

Name Profile # Employees HQ Website

Global antimicrobial resistance diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antimicrobial resistance diagnostics market will help companies and investors design strategic landscapes.


Pcr was the largest segment with a revenue share of 24.71% in 2021. Horizon Databook has segmented the Global antimicrobial resistance diagnostics market based on microbiology culture, immunoassay, pcr, ngs, mass spectrometry, rapid & point of care, other technology covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Antimicrobial Resistance Diagnostics Technology Outlook (Revenue, USD Million, 2018-2030)
    • Microbiology Culture
    • Immunoassay
    • PCR
    • NGS
    • Mass Spectrometry
    • Rapid & Point of Care
    • Other Technology
  • Global Antimicrobial Resistance Diagnostics Pathogen Outlook (Revenue, USD Million, 2018-2030)
    • Drug Resistant Streptococcus Pneumoniae (DRSP)
    • Drug Resistant Campylobacter (DRC)
    • Clostridium Difficile (CD)
    • Methicillin Resistant Staphylococcus Aureus (MRSA)
    • Drug Resistant Neisseria Gonorrhoeae (DRNG)
    • Drug Resistant Salmonella (DRNTS)
    • Other Pathogen
  • Global Antimicrobial Resistance Diagnostics End-user Outlook (Revenue, USD Million, 2018-2030)
    • Hospitals
    • Diagnostic Laboratories
    • Pharmaceutical & Biotechnology Companies
    • Other End-user

Reasons to subscribe to Global antimicrobial resistance diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global antimicrobial resistance diagnostics market databook

  • Our clientele includes a mix of antimicrobial resistance diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global antimicrobial resistance diagnostics market, including forecasts for subscribers. This global databook contains high-level insights into Global antimicrobial resistance diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global antimicrobial resistance diagnostics market report size, by regions, 2018-2030 (US$M)

Top 10 countries: Antimicrobial resistance diagnostics market report size, 2021 (US$M)

Global antimicrobial resistance diagnostics market report share, by technology, 2021 & 2030 (%, US$M)

Antimicrobial resistance diagnostics market: Opportunity assessment by country

Global antimicrobial resistance diagnostics market, by region, 2021 (US$M)

Global antimicrobial resistance diagnostics market report size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more